Abstract
Numerous eligible articles investigated the potential impact of the promoter region of UCP2 (rs659366) variant and the susceptibility for obesity with questionable outcomes. Our team designed this case–control combined with meta-analysis survey to illustrate the contribution of this variant with obesity. This case–control survey was formulated based on 110 obese Egyptian patients and 122 non-obese controls. Genomic DNA was amplified for ascertaining of UCP2 (G-866A; rs659366) variant exploiting the PCR–RFLP technique. A literature search was completed to investigate the involvement of this variant with obesity from various genetic databases. In this case–control study, the distribution of UCP2 (rs659366) variant showed a significant association with obesity among Egyptian subjects under allelic and dominant models (P value = 0.0006 and < 0.001, respectively). Overall, twenty-five comparisons for this variant (8652 obese patients and 10,075 non-obese controls) were recruited in this meta-analysis survey. A noteworthy association of UCP2 (rs659366) variant with obesity was identified among Asians and Africans but not Caucasians under allelic, dominant as well as heterozygote models. Nevertheless, this meta-analysis could not accomplish a noticeable association with overall subjects under different genetic models. This case-controlled study revealed a robust association for UCP2 (rs659366) variant with obesity susceptibility in Egyptian subjects; however, this meta-analysis survey failed to achieve an association for this variant with obesity in overall subjects except among Asians and Africans.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdelmajed SS, Youssef M, Zaki ME, Abu-Mandil Hassan N, Ismail S (2017) Association analysis of FTO gene polymorphisms and obesity risk among Egyptian children and adolescents. Genes Dis 4:170–175. https://doi.org/10.1016/j.gendis.2017.06.002
Ali EMM, Diab T, Elsaid A, Abd El Daim HA, Elshazli RM, Settin A (2019) Fat mass and obesity-associated (FTO) and leptin receptor (LEPR) gene polymorphisms in Egyptian obese subjects. Arch Physiol Biochem. https://doi.org/10.1080/13813455.2019.1573841
Allister EM et al (2013) UCP2 regulates the glucagon response to fasting and starvation. Diabetes 62:1623–1633. https://doi.org/10.2337/db12-0981
Amer T, El-Baz R, Mokhtar AR, El-Shaer S, Elshazli R, Settin A (2017) Genetic polymorphisms of IL-23R (rs7517847) and LEP (rs7799039) among Egyptian patients with hepatocellular carcinoma. Arch Physiol Biochem 123:279–285. https://doi.org/10.1080/13813455.2017.1320680
Andersen G et al (2013) The frequent UCP2 -866G>A polymorphism protects against insulin resistance and is associated with obesity: a study of obesity and related metabolic traits among 17 636 Danes. Int J Obes (Lond) 37:175–181. https://doi.org/10.1038/ijo.2012.22
Arnlov J, Ingelsson E, Sundstrom J, Lind L (2010) Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 121:230–236. https://doi.org/10.1161/circulationaha.109.887521
Brondani LA, de Souza BM, Assmann TS, Boucas AP, Bauer AC, Canani LH, Crispim D (2014) Association of the UCP polymorphisms with susceptibility to obesity: case-control study and meta-analysis. Mol Biol Rep 41:5053–5067. https://doi.org/10.1007/s11033-014-3371-7
Cadenas S (2018) Mitochondrial uncoupling, ROS generation and cardioprotection. Biochim Biophys Acta Bioenerg 1859:940–950. https://doi.org/10.1016/j.bbabio.2018.05.019
Cochran WG (1954) Some methods for strengthening the common χ2 tests. Biometrics 10:417–451. https://doi.org/10.2307/3001616
Dalgaard LT et al (2003) Mutational analysis of the UCP2 core promoter and relationships of variants with obesity. Obestet Res 11:1420–1427. https://doi.org/10.1038/oby.2003.191
de Souza BM et al (2015) Polymorphisms of the UCP2 gene are associated with glomerular filtration rate in type 2 diabetic patients and with decreased UCP2 gene expression in human kidney. PLoS ONE 10:e0132938. https://doi.org/10.1371/journal.pone.0132938
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455–463. https://doi.org/10.1111/j.0006-341x.2000.00455.x
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res Ed) 315:629–634. https://doi.org/10.1136/bmj.315.7109.629
Elshazli R, Settin A, Salama A (2015) Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) +49 A>G gene polymorphism in Egyptian cases with rheumatoid arthritis. Gene 558:103–107. https://doi.org/10.1016/j.gene.2014.12.046
Elshazli RM, Salman DO, Kamel MM, Toraih EA, Fawzy MS (2018) Genetic polymorphisms of IL-17A rs2275913, rs3748067 and IL-17F rs763780 in gastric cancer risk: evidence from 8124 cases and 9873 controls. Mol Biol Rep 45:1421–1444. https://doi.org/10.1007/s11033-018-4202-z
Elshazli RM, Toraih EA, Elgaml A, Kandil E, Fawzy MS (2020) Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies. Gene 734:144391. https://doi.org/10.1016/j.gene.2020.144391
Esterbauer H et al (2001) A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 28:178–183. https://doi.org/10.1038/88911
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502
Gadomska H, Janecki J, Marianowski L, Nowicka G (1997) Lipids in serum of patients with malignant ovarian neoplasms. Int J Gynaecol Obstet 57:287–293
Gayoso-Diz P, Otero-Gonzalez A, Rodriguez-Alvarez MX, Gude F, Garcia F, De Francisco A, Quintela AG (2013) Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord 13:47. https://doi.org/10.1186/1472-6823-13-47
Heidari J, Akrami SM, Heshmat R, Amiri P, Fakhrzadeh H, Pajouhi M (2010) Association study of the -866G/A UCP2 gene promoter polymorphism with type 2 diabetes and obesity in a Tehran population: a case control study. Arch Iran Med 13:384–390
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ (Clin Res Ed) 327:557–560. https://doi.org/10.1136/bmj.327.7414.557
Huriyati E, Luglio HF, Ratrikaningtyas PD, Tsani AF, Sadewa AH, Juffrie M (2016) Dyslipidemia, insulin resistance and dietary fat intake in obese and normal weight adolescents: the role of uncoupling protein 2–866G/A gene polymorphism. Int J Mol Epidemiol Genet 7:67–73
Krempler F et al (2002) A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. Diabetes 51:3331–3335. https://doi.org/10.2337/diabetes.51.11.3331
Kring SI et al (2008) Genotype-phenotype associations in obesity dependent on definition of the obesity phenotype. Obestet Facts 1:138–145. https://doi.org/10.1159/000137665
Lan KKG, DeMets DL (1983) Discrete sequential boundaries for clinical trials. Biometrika 70:659–663. https://doi.org/10.2307/2336502
Li J, Jiang R, Cong X, Zhao Y (2019) UCP2 gene polymorphisms in obesity and diabetes, and the role of UCP2 in cancer. FEBS Lett 593:2525–2534. https://doi.org/10.1002/1873-3468.13546
Lin E, Pei D, Huang YJ, Hsieh CH, Wu LS (2009) Gene-gene interactions among genetic variants from obesity candidate genes for nonobese and obese populations in type 2 diabetes. Genet Test Mol Biomarkers 13:485–493. https://doi.org/10.1089/gtmb.2008.0145
Liu L, Zhao X, Kang S, Zhang D (2013) An association between -866G/A polymorphism in the promoter of UCP2 and obesity: a meta-analysis. Gene 514:41–47. https://doi.org/10.1016/j.gene.2012.11.001
Mahdy T et al (2019) Evaluation of the efficacy of single anastomosis sleeve ileal (SASI) bypass for patients with morbid obesity: a multicenter study. Obestet Surg. https://doi.org/10.1007/s11695-019-04296-3
Mancini FP et al (2003) Variants of uncoupling protein-2 gene and obesity: interaction with peroxisome proliferator-activated receptorgamma2. Clin Endocrinol (Oxf) 59:817–822. https://doi.org/10.1046/j.1365-2265.2003.01926.x
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748
Moher D et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1. https://doi.org/10.1186/2046-4053-4-1
Mosquera-Heredia MI, De Armas-Daza LM, Ospino-Fernández LFJ (2014) Estudio de asociación del polimorfismo -866 G/A del gen UCP2 con obesidad en una población de Valledupar. Cienc Salud 12:157–167. https://doi.org/10.12804/revsalud12.2.2014.02
Oberkofler H, Liu YM, Esterbauer H, Hell E, Krempler F, Patsch W (1998) Uncoupling protein-2 gene: reduced mRNA expression in intraperitoneal adipose tissue of obese humans. Diabetologia 41:940–946. https://doi.org/10.1007/s001250051011
Ochoa MC et al (2007) Association between obesity and insulin resistance with UCP2-UCP3 gene variants in Spanish children and adolescents. Mol Genet Metab 92:351–358. https://doi.org/10.1016/j.ymgme.2007.07.011
Oguzkan-Balci S, Col-Araz N, Nacak M, Araz M, Sabanci H, Balat A, Pehlivan S (2013) Mitochondrial uncoupling protein 2 (UCP2) gene polymorphisms are associated with childhood obesity and related metabolic disorders. J Pediatr Endocrinol Metab 26:277–283. https://doi.org/10.1515/jpem-2012-0267
Oktavianthi S et al (2012) Uncoupling protein 2 gene polymorphisms are associated with obesity. Cardiovasc Diabetol 11:41. https://doi.org/10.1186/1475-2840-11-41
Palmieri F (2013) The mitochondrial transporter family SLC25: identification, properties and physiopathology. Mol Aspects Med 34:465–484. https://doi.org/10.1016/j.mam.2012.05.005
Pinelli M et al (2006) Beta2-adrenergic receptor and UCP3 variants modulate the relationship between age and type 2 diabetes mellitus. BMC Med Genet 7:85. https://doi.org/10.1186/1471-2350-7-85
Pinkney JH, Boss O, Bray GA, Bulmer K, Coppack SW, Mohamed-Ali V (2000) Physiological relationships of uncoupling protein-2 gene expression in human adipose tissue in vivo. J Clin Endocrinol Metab 85:2312–2317. https://doi.org/10.1210/jcem.85.6.6622
Qian L, Xu K, Xu X, Gu R, Liu X, Shan S, Yang T (2013) UCP2 -866G/A, Ala55Val and UCP3 -55C/T polymorphisms in association with obesity susceptibility—a meta-analysis study. PLoS ONE 8:e58939. https://doi.org/10.1371/journal.pone.0058939
Rial E, Gonzalez-Barroso MM, Fleury C, Bouillaud F (1998) The structure and function of the brown fat uncoupling protein UCP1: current status. BioFactors 8:209–219. https://doi.org/10.1002/biof.5520080307
Rodriguez S, Gaunt TR, Day IN (2009) Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 169:505–514. https://doi.org/10.1093/aje/kwn359
Samano R et al (2018) Association between UCP polymorphisms and adipokines with obesity in Mexican adolescents. J Pediatr Endocrinol Metab 31:561–568. https://doi.org/10.1515/jpem-2017-0262
Schauble N, Geller F, Siegfried W, Goldschmidt H, Remschmidt H, Hinney A, Hebebrand J (2003) No evidence for involvement of the promoter polymorphism -866 G/A of the UCP2 gene in childhood-onset obesity in humans. Exp Clin Endocrinol Diabetes 111:73–76. https://doi.org/10.1055/s-2003-39232
Song GG, Bae SC, Kim JH, Lee YH (2013) The PTPN22 C1858T polymorphism and rheumatoid arthritis: a meta-analysis. Rheumatol Int 33:1991–1999. https://doi.org/10.1007/s00296-013-2679-2
Souza BM, Assmann TS, Kliemann LM, Gross JL, Canani LH, Crispim D (2011) The role of uncoupling protein 2 (UCP2) on the development of type 2 diabetes mellitus and its chronic complications. Arq Bras Endocrinol Metabol 55:239–248. https://doi.org/10.1590/s0004-27302011000400001
Srivastava N, Prakash J, Lakhan R, Agarwal CG, Pant DC, Mittal B (2010) A common polymorphism in the promoter of UCP2 is associated with obesity and hyperinsulenemia in northern Indians. Mol Cell Biochem 337:293–298. https://doi.org/10.1007/s11010-009-0311-2
Stroup DF et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008–2012
Toda C, Diano S (2014) Mitochondrial UCP2 in the central regulation of metabolism. Best Pract Res Clin Endocrinol Metab 28:757–764. https://doi.org/10.1016/j.beem.2014.02.006
Totomoch-Serra A, Munoz ML, Burgueno J, Revilla-Monsalve MC, Diaz-Badillo A (2018) Association of common polymorphisms in the VEGFA and SIRT1 genes with type 2 diabetes-related traits in Mexicans. Arch Med Sci 14:1361–1373. https://doi.org/10.5114/aoms.2018.74757
Wang G et al (2016) Effect of dexmedetomidine in preventing postoperative side effects for laparoscopic surgery: a meta-analysis of randomized controlled trials and trial sequential analysis (PRISMA). Medicine 95:e2927. https://doi.org/10.1097/md.0000000000002927
Wang TN, Huang MC, Lin HL, Hsiang CH, Ko AM, Chang WT, Ko YC (2007) UCP2 A55V variant is associated with obesity and related phenotypes in an aboriginal community in Taiwan. Int J Obestet (Lond) 31:1746–1752. https://doi.org/10.1038/sj.ijo.0803648
Warnick GR, Knopp RH, Fitzpatrick V, Branson L (1990) Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem 36:15–19
Whelton PK et al (2017) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2017.11.006
Xie S, Shan XF, Shang K, Xu H, He J, Cai ZG (2014) Relevance of LIG4 gene polymorphisms with cancer susceptibility: evidence from a meta-analysis. Sci Rep 4:6630. https://doi.org/10.1038/srep06630
Yang Q, Xiao T, Guo J, Su Z (2017) Complex relationship between obesity and the fat mass and obesity locus. Int J Biol Sci 13:615–629. https://doi.org/10.7150/ijbs.17051
Yiew SK, Khor LY, Tan ML, Pang CL, Chai VY, Kanachamy SS, Say YH (2010) No association between peroxisome proliferator-activated receptor and uncoupling protein gene polymorphisms and obesity in Malaysian university students. Obestet Res Clin Pract 4:e247–342. https://doi.org/10.1016/j.orcp.2010.03.002
Yuen VG, McNeill JH (2000) Comparison of the glucose oxidase method for glucose determination by manual assay and automated analyzer. J Pharmacol Toxicol Methods 44:543–546
Zhang CY et al (2001) Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 105:745–755. https://doi.org/10.1016/s0092-8674(01)00378-6
Zhang M, Wang M, Zhao ZT (2014) Uncoupling protein 2 gene polymorphisms in association with overweight and obesity susceptibility: a meta-analysis. Meta Gene 2:143–159. https://doi.org/10.1016/j.mgene.2013.10.009
Acknowledgements
The authors are appreciative for the staff members of Specialized Medical Hospital, Mansoura University, Mansoura, Egypt, for their support in choosing participants enrolled in this study.
Author information
Authors and Affiliations
Contributions
Conceptualization: RE and HA-D; Methodology: AE, LL, and RE; Software: RE and ET; Validation, AM, and MEl-E; Formal analysis: AM and LL; Investigation: HA-D; Resources: RE and LL; Data curation: RE; Writing—original draft preparation: AM and LL; Writing—review and editing: RE and ET; Visualization: ET and ME-E; Supervision: RE and ET; Project administration: RE.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no potential conflict of interest related to this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Abd El Daim, H.A., Elsaid, A.M., Mousa, A.A. et al. Unleash the Association of Mitochondrial Uncoupling Protein (UCP2) Promoter Variant (G-866A; rs659366) with Obesity: Stepping from a Case–Control Study to a Meta-analysis. Biochem Genet 58, 738–770 (2020). https://doi.org/10.1007/s10528-020-09973-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-020-09973-y